A Long-term Follow-up Study in Subjects Who Received CTX001
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04208529 |
|
Recruitment Status :
Enrolling by invitation
First Posted : December 23, 2019
Last Update Posted : April 20, 2023
|
Sponsor:
Vertex Pharmaceuticals Incorporated
Collaborator:
CRISPR Therapeutics
Information provided by (Responsible Party):
Vertex Pharmaceuticals Incorporated
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | September 2039 |
| Estimated Study Completion Date : | September 2039 |